Status:
COMPLETED
Hantavirus Nephropathy in North-Eastern France : Severity Risk Factors and Prognostic Tools
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Hantavirus Nephropathy
Hantavirus Infection
Eligibility:
All Genders
18-125 years
Brief Summary
Hantaviruses are emerging pathogens responsible for hemorrhagic fever with renal syndrome. Severity risks factors aren't consensual in litterature, mostly related to scandinavian cohorts. A prognostic...
Eligibility Criteria
Inclusion
- hantavirus proven by serology infection
- age above 18 years
- Hospitalisation
Exclusion
- age under 18 years
- fulfill opposition form
Key Trial Info
Start Date :
May 20 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2024
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT05415904
Start Date
May 20 2022
End Date
July 31 2024
Last Update
February 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Central Hospital
Nancy, France, 54000